No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed

Mouaz H. Al-Mallah, Fabien Hyafil, Gaetano Santulli

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)61-63
Number of pages3
JournalAtherosclerosis
Volume305
DOIs
StatePublished - Jul 2020

Keywords

  • Atherosclerosis
  • Diabetes
  • Linagliptin
  • Animals
  • Dipeptidyl-Peptidase IV Inhibitors
  • Dipeptidyl Peptidase 4
  • Fluorodeoxyglucose F18
  • Diabetes Mellitus, Type 2
  • Inflammation
  • Mice
  • Plaque, Atherosclerotic

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this